Medication use in geriatric populations: dental implications of frequently prescribed medications.
Anticipated demographic changes in the U.S. during the next 20 years will bring increasing numbers of geriatric patients into dental practices. It is expected that these patients will have multiple co-morbid medical conditions and will have to take multiple medications as a result. Dental practitioners must stay informed concerning newly marketed drugs and those commonly prescribed to geriatric patients, and the potential dental implications of those drugs. Specialized training in geriatric dentistry, continuing education, and consultation with medical and pharmacy practitioners can provide valuable tools for managing this special patient population.
Department of Biologic and Diagnostic Sciences, University of Tennessee, College of Dentistry, Memphis, TN, USA.
Mary A
MA
Aubertin
Carlton
C
Horbelt
Waletha
W
Wasson
Marjorie
M
Woods
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D016321:Dental Care for Aged; D004232:Diuretics / Q000627:therapeutic use; D004347:Drug Interactions; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D004498:Education, Dental, Continuing; D005850:Geriatric Dentistry / Q000193:education; D006401:Hematologic Agents / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D019338:Polypharmacy
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000889:Anti-Arrhythmia Agents; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000928:Antidepressive Agents; D050071:Bone Density Conservation Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D006401:Hematologic Agents; D006993:Hypnotics and Sedatives; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents